24 May 2013
Keywords: novartis, sebo, gmbh, sign, hyperphosphatemia, drug, accord
Article | 22 August 2005
Swiss drug major Novartis has signed an agreement with SeBo GmbH of Germany to acquire the global rights for a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 August 2005
23 May 2013
© 2013 thepharmaletter.com